|
Volumn 11, Issue 12, 2016, Pages 1495-1497
|
Boosting clinical translation of nanomedicine
|
Author keywords
artificial organ; clinical translation; nanobiomaterials; nanomedicine; organs on a chip
|
Indexed keywords
NANOMATERIAL;
NANOPARTICLE;
NEW DRUG;
BIOMATERIAL;
BIOMIMETICS;
DRUG APPROVAL;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG SAFETY;
DRUG SYNTHESIS;
ENCAPSULATION;
EXPERIMENTAL MODEL;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LAB ON A CHIP;
MEDICAL RESEARCH;
NANOMEDICINE;
NANOTECHNOLOGY;
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
REVIEW;
TRANSLATIONAL RESEARCH;
UNSPECIFIED SIDE EFFECT;
ANIMAL;
BIOASSAY;
CHEMISTRY;
MEDICINAL CHEMISTRY;
MICROFLUIDICS;
PROCEDURES;
THERANOSTIC NANOMEDICINE;
TRENDS;
ANIMALS;
BIOCOMPATIBLE MATERIALS;
BIOLOGICAL ASSAY;
CHEMISTRY, PHARMACEUTICAL;
DRUG DELIVERY SYSTEMS;
HUMANS;
MICROFLUIDICS;
THERANOSTIC NANOMEDICINE;
TRANSLATIONAL MEDICAL RESEARCH;
|
EID: 84977554901
PISSN: 17435889
EISSN: 17486963
Source Type: Journal
DOI: 10.2217/nnm-2016-0133 Document Type: Review |
Times cited : (42)
|
References (20)
|